Lung Cancer - Is There a Pan Tumor Approval for TDXDA?

The loss of her too is a big thing in gastric, but not so much in breast. Do you envision in the future that maybe there's going to be a pan tumor approval of say TDXDA for just her too mutant disease in general? That's a great question. We just completed a crawl and the jury's still out. And this is specifically looking at the her to mutant solid different types of solid tumors. This is a pretty simple design. You know, if it's a it's the same drug, you give it in a oncogene selected patient population across multiple tumor types.